Live Quote · NASDAQCOEPHealthcare· Biotechnology

Coeptis Therapeutics Holdings, Inc.

$10.99 8.57%($-1.03)
TickerSpark Score
49/100
Weak
53
Valuation
20
Profitability
60
Growth
84
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a COEP research report →

52-Week Range29% of range
Low
$6.80
Current
$10.99
High
$21.41
Company Overviewcoeptistx.com

About the company

Coeptis Therapeutics Holdings, Inc. , together with its subsidiaries, operates as a biopharmaceutical and technology company. The company is developing cell therapy platforms for cancer, autoimmune, and infectious diseases.

CEO
David Mehalick
IPO
2020
Employees
6
HQ
Wexford, PA, US

Price Chart

+20.24% · this period
$18.80$12.93$7.05Jun 10Dec 09Jul 02
Valuation
Market Cap
$38.62M
P/E
-4.49
P/S
48.37
P/B
3.18
EV/EBITDA
-5.74
Div Yield
0.00%
Profitability
Gross Margin
-253.63%
Op Margin
-912.42%
Net Margin
-832.32%
ROE
-82.93%
ROIC
-59.28%
Growth & Income
Revenue
$1.36M · 0.00%
Net Income
$-11,917,015 · -11.58%
EPS
$-2.81 · 50.27%
Op Income
$-13,043,498
FCF YoY
-29.38%
Performance & Tape
52W High
$21.41
52W Low
$6.80
50D MA
$12.25
200D MA
$13.72
Beta
-0.43
Avg Volume
50.88K

Get TickerSpark's AI analysis on COEP

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Apr 24, 26BSG Series CM, LLCother0
Feb 11, 26Cogley Brianother12,500
Feb 11, 26Cogley Brianother10,000
Feb 11, 26Deschamps Philippeother5,700
Feb 11, 26Deschamps Philippeother3,250
Feb 11, 26Calise Chrisother3,250
Feb 11, 26Calise Chrisother5,700
Feb 11, 26Mehalick Davidother148,875
Feb 11, 26Mehalick Davidother51,250
Feb 11, 26Cochran Christopher P.other5,700
Coverage · COEP

Our COEP coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on COEP yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate COEP report →
Internal Compare

Similar companies

Peers in the same neighborhood.